 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
* C-alpha coords only
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
2 terms
|
 |
|
Biological process
|
immune response
|
2 terms
|
 |
|
Biochemical function
|
interleukin-1 receptor binding
|
1 term
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Biochemistry
29:2679-2684
(1990)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of interleukin 1 alpha at 2.7-A resolution.
|
|
B.J.Graves,
M.H.Hatada,
W.A.Hendrickson,
J.K.Miller,
V.S.Madison,
Y.Satow.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The interleukin 1 (IL-1) family of proteins has a central role in modulating
immune and inflammatory responses. Two major IL-1 proteins, designated alpha
(IL-1 alpha) and beta (IL-1 beta), are produced by activated macrophages and
other cell types. In an effort to understand the similarities and differences in
the physicochemical and functional properties of these two proteins, a program
was initiated to determine their structures. Crystals of IL-1 alpha were grown,
and the three-dimensional structure at 2.7-A resolution was solved. The
technique of multiple-wavelength anomalous dispersion (MAD) with the
selenomethionine form of IL-1 alpha was utilized in combination with a single
mercury derivative to provide the starting phases. Partial refinement of the
IL-1 alpha model has been performed as well. The overall structure is composed
of 14 beta-strands and a 3(10) helix. The core of this structure is a capped
beta-barrell that possesses 3-fold symmetry and displays a topology similar to
and soybean trypsin inhibitor (STI) [McLachlan, A. D. (1979) J. Mol. Biol. 133,
557-563]. In this paper, the overall structure of IL-1 alpha and the nature and
fidelity of the internal 3-fold symmetry are discussed. Comparisons with IL-1
beta and STI are made within these contexts.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Gabay,
C.Lamacchia,
and
G.Palmer
(2010).
IL-1 pathways in inflammation and human diseases.
|
| |
Nat Rev Rheumatol, 6,
232-241.
|
 |
|
|
|
|
 |
M.Renko,
J.Sabotic,
M.Mihelic,
J.Brzin,
J.Kos,
and
D.Turk
(2010).
Versatile loops in mycocypins inhibit three protease families.
|
| |
J Biol Chem, 285,
308-316.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Lingel,
T.M.Weiss,
M.Niebuhr,
B.Pan,
B.A.Appleton,
C.Wiesmann,
J.F.Bazan,
and
W.J.Fairbrother
(2009).
Structure of IL-33 and its interaction with the ST2 and IL-1RAcP receptors--insight into heterotrimeric IL-1 signaling complexes.
|
| |
Structure, 17,
1398-1410.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Prudovsky,
F.Tarantini,
M.Landriscina,
D.Neivandt,
R.Soldi,
A.Kirov,
D.Small,
K.M.Kathir,
D.Rajalingam,
and
T.K.Kumar
(2008).
Secretion without Golgi.
|
| |
J Cell Biochem, 103,
1327-1343.
|
 |
|
|
|
|
 |
M.Li,
Y.Huang,
and
Y.Xiao
(2008).
Effects of external interactions on protein sequence-structure relations of beta-trefoil fold.
|
| |
Proteins, 72,
1161-1170.
|
 |
|
|
|
|
 |
G.Vergoten,
and
J.P.Zanetta
(2007).
Structural differences between the putative carbohydrate-recognition domains of human IL-1 alpha, IL-1 beta and IL-1 receptor antagonist obtained by in silico modeling.
|
| |
Glycoconj J, 24,
183-193.
|
 |
|
|
|
|
 |
R.A.Kovall,
and
W.A.Hendrickson
(2004).
Crystal structure of the nuclear effector of Notch signaling, CSL, bound to DNA.
|
| |
EMBO J, 23,
3441-3451.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Lozovaya,
and
A.D.Miller
(2003).
Chemical neuroimmunology: health in a nutshell bidirectional communication between immune and stress (limbic-hypothalamic-pituitary-adrenal) systems.
|
| |
Chembiochem, 4,
466-484.
|
 |
|
|
|
|
 |
N.Kureishy,
V.Sapountzi,
S.Prag,
N.Anilkumar,
and
J.C.Adams
(2002).
Fascins, and their roles in cell structure and function.
|
| |
Bioessays, 24,
350-361.
|
 |
|
|
|
|
 |
S.R.Brych,
S.I.Blaber,
T.M.Logan,
and
M.Blaber
(2001).
Structure and stability effects of mutations designed to increase the primary sequence symmetry within the core region of a beta-trefoil.
|
| |
Protein Sci, 10,
2587-2599.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Liu,
A.J.Chirino,
Z.Misulovin,
C.Leteux,
T.Feizi,
M.C.Nussenzweig,
and
P.J.Bjorkman
(2000).
Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand.
|
| |
J Exp Med, 191,
1105-1116.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.K.Dattagupta,
A.Podder,
C.Chakrabarti,
U.Sen,
D.Mukhopadhyay,
S.K.Dutta,
and
M.Singh
(1999).
Refined crystal structure (2.3 A) of a double-headed winged bean alpha-chymotrypsin inhibitor and location of its second reactive site.
|
| |
Proteins, 35,
321-331.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Ravichandran,
U.Sen,
C.Chakrabarti,
and
J.K.Dattagupta
(1999).
Cryocrystallography of a Kunitz-type serine protease inhibitor: the 90 K structure of winged bean chymotrypsin inhibitor (WCI) at 2.13 A resolution.
|
| |
Acta Crystallogr D Biol Crystallogr, 55,
1814-1821.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.A.Dinarello
(1998).
Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
|
| |
Int Rev Immunol, 16,
457-499.
|
 |
|
|
|
|
 |
T.D.Osslund,
R.Syed,
E.Singer,
E.W.Hsu,
R.Nybo,
B.L.Chen,
T.Harvey,
T.Arakawa,
L.O.Narhi,
A.Chirino,
and
C.F.Morris
(1998).
Correlation between the 1.6 A crystal structure and mutational analysis of keratinocyte growth factor.
|
| |
Protein Sci, 7,
1681-1690.
|
 |
|
|
|
|
 |
B.S.Chang,
R.M.Beauvais,
T.Arakawa,
L.O.Narhi,
A.Dong,
D.I.Aparisio,
and
J.F.Carpenter
(1996).
Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution.
|
| |
Biophys J, 71,
3399-3406.
|
 |
|
|
|
|
 |
A.R.Bernard,
T.N.Wells,
A.Cleasby,
F.Borlat,
M.A.Payton,
and
A.E.Proudfoot
(1995).
Selenomethionine labelling of phosphomannose isomerase changes its kinetic properties.
|
| |
Eur J Biochem, 230,
111-118.
|
 |
|
|
|
|
 |
C.Guo,
S.K.Dower,
D.Holowka,
and
B.Baird
(1995).
Fluorescence resonance energy transfer reveals interleukin (IL)-1-dependent aggregation of IL-1 type I receptors that correlates with receptor activation.
|
| |
J Biol Chem, 270,
27562-27568.
|
 |
|
|
|
|
 |
H.Zhu,
K.Ramnarayan,
J.Anchin,
W.Y.Miao,
A.Sereno,
L.Millman,
J.Zheng,
V.N.Balaji,
and
M.E.Wolff
(1995).
Glu-96 of basic fibroblast growth factor is essential for high affinity receptor binding. Identification by structure-based site-directed mutagenesis.
|
| |
J Biol Chem, 270,
21869-21874.
|
 |
|
|
|
|
 |
S.A.Greenfeder,
T.Varnell,
G.Powers,
K.Lombard-Gillooly,
D.Shuster,
K.W.McIntyre,
D.E.Ryan,
W.Levin,
V.Madison,
and
G.Ju
(1995).
Insertion of a structural domain of interleukin (IL)-1 beta confers agonist activity to the IL-1 receptor antagonist. Implications for IL-1 bioactivity.
|
| |
J Biol Chem, 270,
22460-22466.
|
 |
|
|
|
|
 |
S.R.Price,
and
K.Nagai
(1995).
Protein engineering as a tool for crystallography.
|
| |
Curr Opin Biotechnol, 6,
425-430.
|
 |
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
and
B.W.Matthews
(1993).
Refinement of the structure of human basic fibroblast growth factor at 1.6 A resolution and analysis of presumed heparin binding sites by selenate substitution.
|
| |
Protein Sci, 2,
1274-1284.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Hädener,
P.K.Matzinger,
V.N.Malashkevich,
G.V.Louie,
S.P.Wood,
P.Oliver,
P.R.Alefounder,
A.R.Pitt,
C.Abell,
and
A.R.Battersby
(1993).
Purification, characterization, crystallisation and X-ray analysis of selenomethionine-labelled hydroxymethylbilane synthase from Escherichia coli.
|
| |
Eur J Biochem, 211,
615-624.
|
 |
|
|
|
|
 |
F.Guinet,
J.D.Guitton,
N.Gault,
F.Folliard,
N.Touchet,
J.M.Cherel,
A.Crespo,
A.Destourbe,
P.Bertrand,
and
P.Denefle
(1993).
Interleukin-1 beta-specific partial agonists defined by site-directed mutagenesis studies.
|
| |
Eur J Biochem, 211,
583-590.
|
 |
|
|
|
|
 |
Y.Mitsui,
T.Senda,
T.Shimazu,
S.Matsuda,
and
J.Utsumi
(1993).
Structural, functional and evolutionary implications of the three-dimensional crystal structure of murine interferon-beta.
|
| |
Pharmacol Ther, 58,
93.
|
 |
|
|
|
|
 |
B.Veerapandian,
G.L.Gilliland,
R.Raag,
A.L.Svensson,
Y.Masui,
Y.Hirai,
and
T.L.Poulos
(1992).
Functional implications of interleukin-1 beta based on the three-dimensional structure.
|
| |
Proteins, 12,
10-23.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Veerapandian
(1992).
Structure and function of interleukin-1, based on crystallographic and modeling studies.
|
| |
Biophys J, 62,
112-115.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.A.Stura,
P.Chen,
C.M.Wilmot,
J.H.Arevalo,
and
I.A.Wilson
(1992).
Crystallization studies of glycosylated and unglycosylated human recombinant interleukin-2.
|
| |
Proteins, 12,
24-30.
|
 |
|
|
|
|
 |
M.D.Walkinshaw
(1992).
Protein targets for structure-based drug design.
|
| |
Med Res Rev, 12,
317-372.
|
 |
|
|
|
|
 |
P.Manavalan,
D.L.Swope,
and
R.M.Withy
(1992).
Sequence and structural relationships in the cytokine family.
|
| |
J Protein Chem, 11,
321-331.
|
 |
|
|
|
|
 |
P.R.Young
(1992).
Protein hormones and their receptors.
|
| |
Curr Opin Biotechnol, 3,
408-421.
|
 |
|
|
|
|
 |
V.Carinci,
S.Guida,
M.R.Fontana,
E.Palla,
M.Rossini,
and
M.Melli
(1992).
Processing of interleukin-1 in cells of monocytic lineage is differentiation-dependent.
|
| |
Eur J Biochem, 205,
295-301.
|
 |
|
|
|
|
 |
A.E.Eriksson,
L.S.Cousens,
L.H.Weaver,
and
B.W.Matthews
(1991).
Three-dimensional structure of human basic fibroblast growth factor.
|
| |
Proc Natl Acad Sci U S A, 88,
3441-3445.
|
 |
|
|
|
|
 |
C.S.Wu,
S.A.Thompson,
and
J.T.Yang
(1991).
Basic fibroblast growth factor is a beta-rich protein.
|
| |
J Protein Chem, 10,
427-436.
|
 |
|
|
|
|
 |
E.Labriola-Tompkins,
C.Chandran,
K.L.Kaffka,
D.Biondi,
B.J.Graves,
M.Hatada,
V.S.Madison,
J.Karas,
P.L.Kilian,
and
G.Ju
(1991).
Identification of the discontinuous binding site in human interleukin 1 beta for the type I interleukin 1 receptor.
|
| |
Proc Natl Acad Sci U S A, 88,
11182-11186.
|
 |
|
|
|
|
 |
S.P.Eisenberg,
M.T.Brewer,
E.Verderber,
P.Heimdal,
B.J.Brandhuber,
and
R.C.Thompson
(1991).
Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism.
|
| |
Proc Natl Acad Sci U S A, 88,
5232-5236.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|